Showing results (61-70 of 82) with videos related to
Sort By:
Pageof 9
Cell Discovery|June 4, 2024
Specialized Tfh cell subsets driving type-1 and type-2 humoral responses in lymphoid tissueSaumya Kumar, Afonso P Basto, Filipa Ribeiro, et al.Oncoimmunology|October 27, 2023
CD39<sup>+</sup> conventional CD4<sup>+</sup> T cells with exhaustion traits and cytotoxic potential infiltrate tumors and expand upon CTLA-4 blockadeSabrina N Bossio, Carolina Abrate, Jimena Tosello Boari, et al.Blood Advances|June 9, 2020
Transient antibody targeting of CD45RC inhibits the development of graft-versus-host diseaseLaetitia Boucault, Maria-Dolores Lopez Robles, Allan Thiolat, et al.European Journal of Cancer (Oxford, England : 1990)|October 9, 2019
Immune gene expression in head and neck squamous cell carcinoma patientsCharlotte Lecerf, Maud Kamal, Sophie Vacher, et al.Frontiers in Immunology|August 13, 2021
Polyfunctional KLRG-1<sup>+</sup>CD57<sup>+</sup> Senescent CD4<sup>+</sup> T Cells Infiltrate Tumors and Are Expanded in Peripheral Blood From Breast Cancer PatientsMaria C Ramello, Nicolás G Núñez, Jimena Tosello Boari, et al.European Journal of Cancer (Oxford, England : 1990)|July 28, 2023
Phase Ib/II trial of tipapkinogene sovacivec, a therapeutic human papillomavirus16-vaccine, in combination with avelumab in patients with advanced human papillomavirus16-positive cancersEdith Borcoman, Ana Lalanne, Jean-Pierre Delord, et al.Nature Communications|July 1, 2020
Tumor invasion in draining lymph nodes is associated with Treg accumulation in breast cancer patientsNicolas Gonzalo Núñez, Jimena Tosello Boari, Rodrigo Nalio Ramos, et al.Clinical & Translational Immunology|May 16, 2022
Pseudocowpox virus, a novel vector to enhance the therapeutic efficacy of antitumor vaccinationRodrigo Nalio Ramos, Caroline Tosch, Fiorella Kotsias, et al.Nature Communications|January 22, 2019
Efficient oral vaccination by bioengineering virus-like particles with protozoan surface proteinsMarianela C Serradell, Lucía L Rupil, Román A Martino, et al.Nature Communications|October 7, 2016
Loss of immune tolerance to IL-2 in type 1 diabetesLouis Pérol, John M Lindner, Pamela Caudana, et al.Pageof 9